STEMI
0
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Rhythm PharmaceuticalsBOSTON, MA
2 programsThe coronary sinus balloon pumpN/A1 trial
the coronary sinus balloon pumpN/A1 trial
Active Trials
T-TherapeuticsUK - Cambridge
1 programDosing Oxidative stress biomarkers & hFABP in STEMI pPCI patientsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Rhythm PharmaceuticalsThe coronary sinus balloon pump
Rhythm Pharmaceuticalsthe coronary sinus balloon pump
ZollSSO2 therapy
T-TherapeuticsDosing Oxidative stress biomarkers & hFABP in STEMI pPCI patients
Miracor MedicalPiCSO
Clinical Trials (5)
Total enrollment: 187 patients across 5 trials
The Coronary Sinus Balloon Pump in STEMI
Start: Feb 2026Est. completion: Jun 2026177 patients
N/ANot Yet Recruiting
The First-In-Man Use of Coronary Sinus Balloon Pump in STEMI Patients Treated by Primary PCI
Start: Aug 2025Est. completion: Mar 202610 patients
N/ANot Yet Recruiting
Super Saturated Oxygen (SSO2) Therapy in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Action on Coronary Microcirculation Dysfunction
Start: Mar 2023Est. completion: Jun 2025
N/ACompleted
Correlations Between Oxidative Stress Biomarkers, h-FABP and Left Ventricular Dysfunction in Patients With Acute Myocardial Infarction Undergoing Primary PCI
Start: Aug 2019Est. completion: Aug 2020
N/AUnknown
Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction
Start: Jul 2019Est. completion: Feb 2023
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space